These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6208211)

  • 1. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents.
    Gourmelen M; Le Bouc Y; Girard F; Binoux M
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1197-203. PubMed ID: 6208211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of insulin-like growth factor (IGF) and IGF-binding protein in constitutionally short children and adolescents.
    Binoux M; Gourmelen M; Girard F
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):145-52. PubMed ID: 2429488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in insulin-dependent diabetics during an episode of severe metabolic decompensation and the recovery phase.
    Rieu M; Binoux M
    J Clin Endocrinol Metab; 1985 Apr; 60(4):781-5. PubMed ID: 2579089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels.
    Binoux M; Seurin D; Lassarre C; Gourmelen M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):453-62. PubMed ID: 6205015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children.
    Garrone S; Radetti G; Sidoti M; Bozzola M; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5455-60. PubMed ID: 12466336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
    Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of the IGF (insulin-like growth factors or somatomedins) competitive binding assay in the study of growth disorders in children (results for 124 observations) (author's transl)].
    Gourmelen M; Girard F; Binoux M
    Arch Fr Pediatr; 1980; 37 Suppl 2():XXXIII-XXXVIII. PubMed ID: 7447617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.
    Tönshoff B; Blum WF; Wingen AM; Mehls O
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2684-91. PubMed ID: 7545697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statural development parallels IGF I levels in subjects of constitutionally variant stature.
    Binoux M; Gourmelen M
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):524-30. PubMed ID: 3577585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone.
    Johansen JS; Giwercman A; Hartwell D; Nielsen CT; Price PA; Christiansen C; Skakkebaek NE
    J Clin Endocrinol Metab; 1988 Aug; 67(2):273-8. PubMed ID: 3260598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
    J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.